Literature DB >> 22706900

Sclerostin: A new mediator of crosstalk between the skeletal and immune systems.

Mark C Horowitz1, Jackie A Fretz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22706900     DOI： 10.1002/jbmr.1672

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN： 0884-0431            Impact factor:   6.741


× No keyword cloud information.
  4 in total

1.  Fibroblast Growth Factor 23 and Anemia in the Chronic Renal Insufficiency Cohort Study.

Authors:  Rupal Mehta; Xuan Cai; Alexander Hodakowski; Jungwha Lee; Mary Leonard; Ana Ricardo; Jing Chen; Lee Hamm; James Sondheimer; Mirela Dobre; Valentin David; Wei Yang; Alan Go; John W Kusek; Harold Feldman; Myles Wolf; Tamara Isakova
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-07       Impact factor: 8.237

Review 2.  The Effects of Sclerostin on the Immune System.

Authors:  Cristine Donham; Jennifer O Manilay
Journal:  Curr Osteoporos Rep       Date:  2020-02       Impact factor: 5.096

3.  Serum Sclerostin Levels in Patients with Human Immunodeficiency Virus Infection and Their Association with Bone Turnover Markers and Bone Mineral Densitometry.

Authors:  Abdulrahman Y Almansouri; Mohammed E Abdulfatah; Omar H Baaqil; Alaa A Bakheet; Sarah A Turki; Mamdouh M Kotb; Alaa Althubaiti; Majed M Almaghrabi; Abdulrahman M Althubaiti; Badr M Madani; Ali S M Jawad
Journal:  J Bone Metab       Date:  2016-02-29

Review 4.  The Roles of Sclerostin in Immune System and the Applications of Aptamers in Immune-Related Research.

Authors:  Meiheng Sun; Zihao Chen; Xiaoqiu Wu; Yuanyuan Yu; Luyao Wang; Aiping Lu; Ge Zhang; Fangfei Li
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.